Boston, MA -- (SBWIRE) -- 02/04/2014 -- Global Market Direct's pharmaceuticals report, "Medisyn Technologies, Inc. - Product Pipeline Review - 2013" provides data on the Medisyn Technologies, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Medisyn Technologies, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Medisyn Technologies, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- Medisyn Technologies, Inc. - Brief Medisyn Technologies, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Medisyn Technologies, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Medisyn Technologies, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Medisyn Technologies, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Medisyn Technologies, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Medisyn Technologies, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Medisyn Technologies, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Medisyn Technologies, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Medisyn Technologies, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Medisyn Technologies, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Flamel Technologies S.A. - Product Pipeline Review - 2013
- Dynavax Technologies Corporation - Product Pipeline Review - 2013
- Applied Genetic Technologies Corporation - Product Pipeline Review - 2013
- MSM Protein Technologies, Inc. - Product Pipeline Review - 2013
- ArmaGen Technologies, Inc. - Product Pipeline Review - 2013
- to-BBB technologies BV - Product Pipeline Review - 2013
- Aurigene Discovery Technologies Limited - Product Pipeline Review - 2013
- Adherex Technologies Inc. - Product Pipeline Review - 2013
- SIGA Technologies, Inc. - Product Pipeline Review - 2013
- Palatin Technologies, Inc. - Product Pipeline Review - 2013